Infectious disease

Increasing Drug-Resistance By Superbugs May Lead To Another Global Healthcare Crisis

by

Researchers are flagging a growing problem in the world of infectious disease and antimicrobials: superbugs are becoming increasingly resistant to the therapies and drugs that are used to fight them. In fact, the World Health Organization has warned that nearly one in six infection-causing microbes are resistant to antibiotic treatments. Furthermore, its report also indicates … Read more

COVID-19 Data & Policy Tracker: Cases, Deaths & Government Responses (2023)

by

Archyde The ongoing monitoring of COVID-19’s global impact relies on a complex network of data collection and analysis. For years, researchers and public health officials have tracked cases, deaths, and the… You can read the full story here: COVID-19 Data & Policy Tracker: Cases, Deaths & Government Responses (2023). Source link

Moderna Flu Vaccine: FDA Review Delay & President’s Response

by

Archyde FDA’s Rejection of Moderna’s Flu Vaccine Signals a Potential Shift in Vaccine Regulation Nearly a billion dollars. That’s approximately how much Moderna invested in a Phase 3 clinical trial for… You can read the full story here: Moderna Flu Vaccine: FDA Review Delay & President’s Response. Source link

One-in-ten infectious disease deaths linked to obesity – study

by

Lancet paper found that people living with obesity are 70 per cent more likely to likely to be hospitalised or die from an infectious disease One-in-ten infectious disease deaths globally are potentially linked to obesity, a new study in the Lancet has found Research involving over 540,000 people also uncovered that people living with obesity … Read more

Singapore steps up public health safeguards as local measles cases increase amid global surge

by

Singapore recorded 11 measles cases in January 2026, all involving unvaccinated individuals, as global infections surpass pre-pandemic levels and imported cases pose ongoing risks. The Communicable Diseases Agency has stepped up isolation, quarantine, contact tracing and post-exposure prophylaxis, with enforcement measures in place to curb potential community transmission. Health authorities urge the public to ensure … Read more

HIV can develop resistance to lenacapavir, but at a cost to the virus

by

  Since its first approval in 2022, Gilead Sciences’ lenacapavir—a twice-yearly injectable—has come to be a potential game changer for preventing HIV and for treating multidrug-resistant HIV, where it’s used in combination with other antiretrovirals. The drug targets the HIV-1 capsid protein and inhibits viral replication.